Search research articles
Contact Us
Filters
Showing results (81-90 of 128) with videos related to
Page
of 13
Sort By:
Magnetic Resonance in Medicine
|
March 18, 2011
Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla
Mary A McLean, Tristan Barrett, Vincent J Gnanapragasam, et al.
Cancer Research
|
October 28, 2016
Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3'-Deoxy-3'-[18F]Fluorothymidine in Preclinical Models of Lung Cancer
Sonja Schelhaas, Annelena Held, Lydia Wachsmuth, et al.
Neoplasia (New York, N.Y.)
|
May 14, 2004
Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model
Dominick J O McIntyre, Simon P Robinson, Franklyn A Howe, et al.
NMR in Biomedicine
|
January 16, 2016
Classification of brain tumours from MR spectra: the INTERPRET collaboration and its outcomes
Margarida Julià-Sapé, John R Griffiths, A Rosemary Tate, et al.
Plos One
|
May 20, 2014
BCR-ABL affects STAT5A and STAT5B differentially
Michael Schaller-Schönitz, David Barzan, Andrew J K Williamson, et al.
British Journal of Haematology
|
April 1, 2008
THOC5 spliceosome protein: a target for leukaemogenic tyrosine kinases that affects inositol lipid turnover
Andrew Pierce, Louise Carney, Hajja G Hamza, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
July 2, 2013
Muscle metabolism and activation heterogeneity by combined 31P chemical shift and T2 imaging, and pulmonary O2 uptake during incremental knee-extensor exercise
Daniel T Cannon, Franklyn A Howe, Brian J Whipp, et al.
Magnetic Resonance in Medicine
|
August 1, 2009
Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T
Mary A McLean, Andrew N Priest, Ilse Joubert, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
July 28, 2004
Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice
Manuel Mayr, Bernhard Metzler, Yuen-Li Chung, et al.
European Radiology
|
November 1, 2016
Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations
Reem Bedair, Andrew N Priest, Andrew J Patterson, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 128) with videos related to
Sort By:
Page
of 13
Magnetic Resonance in Medicine
|
March 18, 2011
Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla
Mary A McLean, Tristan Barrett, Vincent J Gnanapragasam, et al.
Cancer Research
|
October 28, 2016
Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3'-Deoxy-3'-[18F]Fluorothymidine in Preclinical Models of Lung Cancer
Sonja Schelhaas, Annelena Held, Lydia Wachsmuth, et al.
Neoplasia (New York, N.Y.)
|
May 14, 2004
Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model
Dominick J O McIntyre, Simon P Robinson, Franklyn A Howe, et al.
NMR in Biomedicine
|
January 16, 2016
Classification of brain tumours from MR spectra: the INTERPRET collaboration and its outcomes
Margarida Julià-Sapé, John R Griffiths, A Rosemary Tate, et al.
Plos One
|
May 20, 2014
BCR-ABL affects STAT5A and STAT5B differentially
Michael Schaller-Schönitz, David Barzan, Andrew J K Williamson, et al.
British Journal of Haematology
|
April 1, 2008
THOC5 spliceosome protein: a target for leukaemogenic tyrosine kinases that affects inositol lipid turnover
Andrew Pierce, Louise Carney, Hajja G Hamza, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
July 2, 2013
Muscle metabolism and activation heterogeneity by combined 31P chemical shift and T2 imaging, and pulmonary O2 uptake during incremental knee-extensor exercise
Daniel T Cannon, Franklyn A Howe, Brian J Whipp, et al.
Magnetic Resonance in Medicine
|
August 1, 2009
Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T
Mary A McLean, Andrew N Priest, Ilse Joubert, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
July 28, 2004
Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice
Manuel Mayr, Bernhard Metzler, Yuen-Li Chung, et al.
European Radiology
|
November 1, 2016
Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations
Reem Bedair, Andrew N Priest, Andrew J Patterson, et al.
Page
of 13